PyInvesting

Market research

POLYMED.NSE Poly Medicure Limited

NSE INR Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
176B
P/E ratio
55.88
Analyst target
1824.8334
Dividend yield
0.0%
Beta
0.01

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Poly Medicure Limited is currently in a long term uptrend where the price is trading 36.9% above its 200 day moving average.

From a valuation standpoint, the stock is 113.0% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 10.2.

Poly Medicure Limited's total revenue rose by 12.8% to $2B since the same quarter in the previous year.

Its net income has increased by 41.1% to $353M since the same quarter in the previous year.

Finally, its free cash flow grew by 39.0% to $849M since the same quarter in the previous year.

Based on the above factors, Poly Medicure Limited gets an overall score of 4/5.